Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Haleon (HLN)

Price 388.10p on 21-02-2025 at 10:28:00
Change 2.20p 0.57%
Buy 388.10p
Sell 387.90p
Buy / Sell HLN Shares
Last Trade: Buy 561.00 at 388.10p
Day's Volume: 2,599,267
Last Close: 385.90p
Open: 383.90p
ISIN: GB00BMX86B70
Day's Range 383.10p - 389.30p
52wk Range: 310.85p - 400.50p
Market Capitalisation: £35,099m
VWAP: 387.29253p
Shares in Issue: 9,044m

Recent Trades History Haleon (HLN)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 561 388.10p Automatic Execution
10:27:47 - 21-Feb-25
Buy* 560 388.00p Automatic Execution
10:27:45 - 21-Feb-25
Buy* 1,331 388.00p Automatic Execution
10:27:42 - 21-Feb-25
Buy* 1,337 388.00p Automatic Execution
10:27:42 - 21-Feb-25
Buy* 1,010 388.00p Automatic Execution
10:27:42 - 21-Feb-25
Buy* 2,034 388.00p Automatic Execution
10:27:42 - 21-Feb-25
Buy* 800 387.80p Automatic Execution
10:26:34 - 21-Feb-25
Buy* 1,987 387.80p Automatic Execution
10:26:34 - 21-Feb-25
Buy* 989 387.80p Automatic Execution
10:26:34 - 21-Feb-25
Sell* 673 387.80p Automatic Execution
10:26:20 - 21-Feb-25

Share Price History for Haleon

Time period:
to
Date Open High Low Close Volume

Share News for Haleon

After bumper 2024, Futura warns of lower 2025 sales on slow US uptake

31st Jan 2025 11:39

(Alliance News) - Futura Medical PLC on Friday said it expects 2024 revenue and post-tax profit ahead of guidance, but warned of 2025 sales below market expectations, due to slow uptake in the US of its erectile dysfunction treatment. Read More

LONDON BROKER RATINGS: JD Sports cut; HSBC raises Legal & General

27th Jan 2025 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

IN BRIEF: Futura gets good results for female sexual dysfunction aid

16th Jan 2025 09:37

Futura Medical PLC - Guildford, Surrey-based sexual health products - Shares rise 4.5% on Wednesday as Futura reports positive results from a 'sensory' study of its WSD4000 treatment for sexual dysfunction in women. Futura explains that a sensory study assesses how healthy volunteers perceive product characteristics through their senses. The study involved 67 women with some degree of sexual dysfunction, and WSD4000 produced a positive change in a majority of them after four weeks. "Following the success of the study, alongside market research on the size of the opportunity following commercialisation, the board is recommending to proceed with an early feasibility study during H1 2025," Futura says. Read More

UPDATE: Pfizer cuts stake in Haleon to 7% in GBP2.5 billion share sale

15th Jan 2025 08:43

(Alliance News) - Pfizer Inc sold 700 million shares in Haleon PLC, as planned, more than halving its remaining stake, placing agent JPMorgan Securities PLC confirmed on Wednesday. Read More

LONDON BRIEFING: Stocks to rise as UK consumer inflation slows

15th Jan 2025 07:50

(Alliance News) - Stocks in London are set to open higher on Wednesday, following consumer and producer price inflation data from the UK, ahead of CPI data from the US. Read More

FTSE 100 Latest
Value8,677.55
Change14.58

Login to your account

Forgot Password?

Not Registered